Metraipolis › archive › dc_211ee1dd2a44

Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis — Europe PMC PMID:40632590

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40632590
DOI
10.1093/oncolo/oyaf203
License (as archived)
solo-consultazione
Archived
2026-11-10T05:17:00.104Z
SHA-256 of the archived text
ac6561f1d545fdc1d219488ccaa6a909cc4e936454662c800a302d8cfb2e047b
Stable URL of this page
https://metraipolis.com/documento/dc_211ee1dd2a44

How to cite

Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis — Europe PMC PMID:40632590 — Europe PMC (en), https://europepmc.org/article/MED/40632590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_211ee1dd2a44 (Metraipolis archive dc_211ee1dd2a44, sha256 ac6561f1d545fdc1d219488ccaa6a909cc4e936454662c800a302d8cfb2e047b)
BibTeX
@misc{dc211ee1dd2a44,
  title = {Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis — Europe PMC PMID:40632590},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40632590},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_211ee1dd2a44; sha256 ac6561f1d545fdc1d219488ccaa6a909cc4e936454662c800a302d8cfb2e047b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40632590. Agents can read the archived copy with the MCP tool read_document.